Aura Biosciences (AURA) Stock Forecast & Price Target
Score
Aura Biosciences, Inc. price target
| AURA | |
|---|---|
| Low | $17.00 |
| Average | $17.50 |
| High | $18.00 |
| Upside vs current price | +146.1% |
The average target of $17.50 is +146.1% versus the current AURA price of $7.11.
Aura Biosciences, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 1 |
| Buy | 5 |
| Hold | 0 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
6 analysts cover AURA.
Aura Biosciences, Inc. EPS and revenue estimates
AURA shows the next fiscal years with at least three analysts: 2026 EPS $-1.67, 2027 EPS $-1.52. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $-1.67 | $19.20M |
| 2027 | $-1.52 | $4.92M |
Is Aura Biosciences, Inc. a buy or sell?
Of the 6 analysts covering Aura Biosciences, Inc., 6 rate it a buy (1 strong buy and 5 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The AURA consensus label is Buy, beside 6 buy-side ratings and 0 sell-side ratings.
The average target of $17.50 implies +146.1% versus the current price of $7.11.
Those 6 ratings on AURA are a headcount, and the label on file is Buy.
Reading the Aura Biosciences, Inc. forecast
The AURA targets sit in a narrow band, from $17.00 to $18.00, around an average of $17.50.
Set next to the $7.11 AURA quote, that average is +146.1%.
Ratings on the Aura Biosciences, Inc. cluster: 6 of 6 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.
The AURA EPS path from 2026 ($-1.67) to 2027 ($-1.52) is rising.
Only 6 analysts cover AURA, so the average rests on a short list.
Aura Biosciences, Inc. forecast questions
What is the AURA price target?
The published range for AURA is $17.00 to $18.00, with an average of $17.50. That average is +146.1% versus the current price of $7.11.
Is Aura Biosciences, Inc. a buy or sell?
Of the 6 analysts covering Aura Biosciences, Inc., 6 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the AURA headcount is 6 buy, 0 hold, and 0 sell.
What is the EPS estimate for Aura Biosciences, Inc.?
Analyst EPS estimates for Aura Biosciences, Inc.: 2026 $-1.67, 2027 $-1.52.
What is the revenue estimate for Aura Biosciences, Inc.?
Analyst revenue estimates for Aura Biosciences, Inc.: 2026 $19.20M, 2027 $4.92M.
How many analysts cover AURA?
6 analysts cover AURA. Their consensus on AURA is Buy, across those 6.